Bionexo
Bionexo is a Brazil-headquartered healthtech that operates an integrated healthcare platform connecting hospitals, clinics, laboratories, operators, and suppliers across five Latin American countries through supply chain, revenue cycle, clinical, and AI solutions.
- Company typePrivate
- Founded1998
- HeadquartersSão Paulo, Brazil
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Bionexo does
Bionexo is a São Paulo–headquartered healthtech platform that connects buyers and suppliers across the Latin American healthcare ecosystem. Founded in 1998 and backed by Bain Capital, the company serves more than 11,000 clients including hospitals, clinics, laboratories, health insurance operators, distributors, and industry across Brazil, Argentina, Colombia, Mexico, and Ecuador, reaching over 90 million patients and 1.2 million users through its platforms. It operates the largest healthcare B2B marketplace in Latin America, with 4,500+ connected institutions and 35+ suppliers transacting through it.
The product portfolio is structured as a platform-plus-modules architecture. Bionexo 360° is the integrated Plan-to-Cash system covering procurement, marketplace purchasing, electronic invoicing (BioNFe), OPME management, RFID traceability (Biotracker), eligibility, billing, and denial appeals. Tasy — acquired from Philips for $193 million in 2026 and the first EMR regularized as a medical device by ANVISA in Brazil — adds clinical, operational, and financial hospital management with modules for oncology, radiology (RIS), laboratories (LIS), primary care, and health insurance operators. Clínica nas Nuvens provides a cloud-based clinic ERP, while Brasíndice (integrated in 2025, with a 60+ year history) delivers the national pharmaceutical pricing reference. The LIA AI layer, with 20+ specialized agents for purchasing, RCM, and clinical workflows, sits across the stack and is complemented by acquired capabilities (Avatar, Tradimus, Overmind, BeeCare) for revenue cycle management and RPA. All cloud infrastructure runs on Oracle Cloud with LGPD compliance.
Bionexo monetizes through SaaS subscriptions for Tasy, Bionexo 360°, and Clínica nas Nuvens; transaction fees on the healthcare marketplace; Brasíndice subscriptions across Basic, Intermediate, Advanced, and printed tiers; and professional services for implementation and customization. Distribution is primarily enterprise field sales supplemented by self-serve platform access, with localized support offices in each of the five operating countries. Pricing is quote-based for enterprise solutions, while Brasíndice pricing is publicly disclosed. The company is privately held by Bain Capital and is pursuing an active M&A strategy, having completed multiple acquisitions since 2022 to expand its RCM, financial, and clinical capabilities.
Bionexo firmographics
Firmographics- Name
- Bionexo
- Legal name
- BIONEXO S.A.
- Website
- https://bionexo.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Bionexo is a Brazil-headquartered healthtech that operates an integrated healthcare platform connecting hospitals, clinics, laboratories, operators, and suppliers across five Latin American countries through supply chain, revenue cycle, clinical, and AI solutions.
- Ownership category
- akta.pro rank
Bionexo industry classification
Industry- Product category
- Healthcare SaaS / Hospital Management Software
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
- akta.pro secondary industries
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Pharmaceuticals & Life Sciences Forwarding (GxP/GDP) (TLACAJAB), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Bionexo is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices6 records
Markets served
Bionexo business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Subscription Licensing: Software licensing fees for access to Bionexo 360°, Tasy, Clínica nas Nuvens, and other digital health solutions. Delivered as subscription-based licensing with annual or multi-year contract terms.
- Healthcare Marketplace Transaction Fees: B2B marketplace connecting healthcare suppliers and buyers. The platform processes purchases and transactions for the largest healthcare marketplace in Latin America.
- Brasíndice Subscriptions: Pricing reference database subscriptions with multiple tiers: Basic Online, Intermediate Online (with data export by state), Advanced Online (with national data export), and printed magazine subscriptions.
- Professional Services: Implementation services, training, customization, and additional support services for platform deployment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Basic Online - Single user online access for 12 months |
| Subscription | Annual | Intermediate Online - Online access with state-level data export |
| Subscription | Annual | Advanced Online - Full national data export capability |
| Subscription | Annual | Printed Magazine - Biweekly printed publication delivery |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels10 records
Bionexo product offering
Product offeringCore offering
Bionexo is a Latin American healthtech platform that develops and operates digital solutions for healthcare institutions. Its portfolio includes Bionexo 360° (an integrated supply chain to revenue cycle platform and B2B healthcare marketplace), Tasy (an ANVISA-certified hospital and clinical management system with electronic medical records), Clínica nas Nuvens (cloud-based clinic ERP), Brasíndice (national pharmaceutical pricing reference since 1965), and the LIA AI layer. The company connects hospitals, clinics, laboratories, health insurance operators, distributors and suppliers across Brazil, Argentina, Colombia, Mexico and Ecuador.
Product overview
Bionexo is a comprehensive health technology platform in Latin America operating under a platform-plus-modules architecture. The core offerings include Bionexo 360° (an integrated Plan to Cash platform connecting supplies to financial operations) and Tasy (a complete integrated health management system for operators and providers). These platforms are supplemented by specialized modules including Tasy RIS for radiology, Tasy LIS for laboratories, Tasy Oncology for chemotherapy management, and Clínica nas Nuvens for cloud-based clinic management. The product portfolio also includes acquired brands like Avatar and Tradimus for revenue cycle management, Brasíndice (pricing reference since 1965), Bioanalytics for market intelligence, Biotracker for RFID traceability, BioNFe for electronic invoices, BioPay for financial management, and Overmind for RPA automation. The AI layer LIA (Lenguaje Inteligente Analítico) powers intelligent agents across the ecosystem for process automation, optimization, and predictive analytics. The company serves hospitals, clinics, laboratories, health insurance operators, distributors, and healthcare industry across Brazil, Argentina, Colombia, Mexico, and Ecuador.
Differentiator
Problem solved
Functional benefit
Brands
- Tasy: Integrated health management system for operators and healthcare providers, including electronic medical records, hospital management, and clinical operations.
- Clínica nas Nuvens
- Brasíndice
- LIA (Linguagem Inteligente Analítico)
- Bionexo 360°
Products and services
- Bionexo 360°
Quantifiable outcome
- 14.1% savings in purchasing costs (Unimed Piracicaba)
- +11 more outcomes
Companies that use Bionexo
Customer profileNamed customers17 records
Segments10 records
Ideal customer profiles5 records
Bionexo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature11 records
Bionexo partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered flagship, core and strategic.
- PhilipsflagshipBionexo acquired Philips' Brazilian EMR business Tasy for $193 million. This strategic acquisition significantly expanded Bionexo's hospital management capabilities and customer base in Latin America.
- Semantix, Inc.coreAcquired Tradimus Consultoria e Serviços em T.i. Ltda. from Semantix, Inc. Semantix is a Brazil-based data platform developer specializing in digital transformation and data analytics solutions.
- Avatar SoluçõescoreBionexo acquired 100% of Avatar, a healthtech company specializing in SaaS solutions for revenue cycle management. Founded in 2017, based in São Paulo, focused on automating medical billing processes.
- TradimuscoreBionexo announced acquisition of Tradimus, a company focused on financial and operational efficiency solutions for hospitals, clinics, and laboratories. Deal pending CADE regulatory approval. Adds R$8 billion in processed medical accounts annually.
- Oracle CloudcoreInfrastructure provider for Bionexo's cloud solutions. All solutions are hosted on Oracle Cloud infrastructure ensuring security, scalability, and reliability.
- FIPE (Fundação Instituto de Pesquisas Econômicas)strategicPartnership for healthcare price indices development. Created IPMH (Índice de Preços de Medicamentos e Materiais Hospitalares) and OPME index in alliance with FIPE.
Scale indicators23 records
Recent moves8 records
Expansion highlights7 records
Bionexo competitors and assessment
Company assessmentDirect peers
- MV Sistemas (MV Saúde): Brazilian hospital information system provider serving hospitals and health operators across Latin America. Directly competes with Bionexo's Tasy and Bionexo 360° in the integrated HIS/RCM category for Brazilian healthcare institutions.
- Pixeon: Brazilian healthcare IT company specializing in radiology (PACS/RIS) and laboratory information systems. Directly overlaps with Bionexo's Tasy RIS and Tasy LIS modules in the diagnostic imaging and clinical lab segments.
- Waystar: US healthcare revenue cycle management platform serving hospitals and health systems. Directly comparable to Bionexo's Avatar, Tradimus, and Bionexo 360° revenue cycle offerings, providing a benchmark for global RCM software economics.
- R1 RCM: Hospital-focused revenue cycle management company (taken private by TowerBrook/CD&R in 2024). Operates in the same end-to-end RCM category as Bionexo's Avatar and Tradimus solutions, with comparable customer base of US health systems.
Broad incumbents
- TOTVS: Brazil's largest enterprise software vendor with a healthcare vertical (TOTVS Saúde). Operates across ERP, HR, and healthcare management — overlapping with Bionexo's broader clinic and hospital management portfolio but not specializing in Bionexo's niche.
- Philips (Health Technology): Global health technology company that divested its Brazilian EMR business (Tasy) to Bionexo for $193M. Continues to operate in adjacent areas (diagnostic imaging, patient monitoring) where Bionexo's installed base competes for capital budgets.
- Oracle Health (Cerner): Global EMR and healthcare IT giant post-Cerner acquisition. Operates broadly across hospital information systems worldwide and represents a major incumbent competitor if it chose to deepen presence in the Brazilian/LatAm market.
- Epic Systems: US-based EMR leader serving large academic medical centers and health systems. While not actively commercializing in Brazil, Epic represents the global benchmark for integrated EMR and could expand into LatAm via large hospital partnerships.
- GE HealthCare: Global medical imaging, monitoring, and healthcare IT vendor. Overlaps with Bionexo's Tasy RIS/radiology and LIS modules as part of a broader imaging and diagnostics portfolio, particularly in enterprise hospital deals.
- Veradigm (formerly Allscripts): US-listed healthcare IT vendor with ambulatory EHR, practice management, and revenue cycle solutions. Broad incumbent in healthcare IT that shares comparable RCM and clinical management capabilities with Bionexo's portfolio.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Bionexo social profiles
Digital presenceBionexo compliance and trust
Trust signalCompliance3 records
Bionexo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionexo leadership team
Management profileNumber of profiles
Profiles5 records
Bionexo subsidiaries and ownership
Company hierarchySubsidiaries4 records
Bionexo funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionexo M&A and investment
M&A and investmentM&A8 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionexo
What does Bionexo do?
Bionexo is a Latin American healthtech platform that develops and operates digital solutions for healthcare institutions. Its portfolio includes Bionexo 360° (an integrated supply chain to revenue cycle platform and B2B healthcare marketplace), Tasy (an ANVISA-certified hospital and clinical management system with electronic medical records), Clínica nas Nuvens (cloud-based clinic ERP), Brasíndice (national pharmaceutical pricing reference since 1965), and the LIA AI layer. The company connects hospitals, clinics, laboratories, health insurance operators, distributors and suppliers across Brazil, Argentina, Colombia, Mexico and Ecuador.
Is Bionexo a public or private company?
Bionexo is a private company. It is classified as private equity controlled and is currently operating.
When was Bionexo founded?
Bionexo was founded in 1998. It employs 251 to 500 people.
Where is Bionexo based?
Bionexo is headquartered in São Paulo, Brazil, in the Latin America region.
How does Bionexo make money?
Four revenue lines are on record. SaaS Subscription Licensing is the primary driver. The others are healthcare Marketplace Transaction Fees, brasíndice Subscriptions and professional Services.
Who are Bionexo's main competitors?
Direct peers on record are MV Sistemas (MV Saúde), Pixeon, Waystar and R1 RCM. Broad incumbents are TOTVS, Philips (Health Technology), Oracle Health (Cerner), Epic Systems, GE HealthCare and Veradigm (formerly Allscripts).
Does Bionexo have an API?
Yes. Tasy Open API is a centralized and secure platform designed to simplify integration between the Tasy system and other health ecosystem applications. Through a standardized portal, institutions and partners can develop connections independently, quickly, and scalably. Features include: self-service with a complete API catalog and sandbox environment for testing, enabling integrations without depending on external support; advanced security with rigorous authentication protocols and encryption; standardization with official and documented APIs ensuring compatibility and specialized technical support; and cloud scalability supporting from small clinics to large hospital networks. Developer documentation is at bionexo.com/tasy-open-api.
What industry is Bionexo in?
Bionexo's product category is Healthcare SaaS / Hospital Management Software. Its primary akta.pro industry code is HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control), with a secondary code of HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 339112 and its SIC code is 3841.